Table 3 Baseline characteristics and coronary CTA findings associated with MACE.

From: Prognostic value of coronary CTA-based classifications for predicting major events without obstructive coronary artery disease

 

Univariable HR (95% CI)

P-value

Multivariable HR (95% CI)

P-value

Age (years)

  < 60

Reference

 

Reference

 

  ≥ 60

2.78 (2.16–3.58)

 < 0.001

2.58 (2.00–3.36)

 < 0.001

Male gender

1.77 (1.41–2.21)

 < 0.001

1.68 (1.29–2.19)

 < 0.001

Smoke

1.52 (1.20–1.94)

0.001

1.18 (0.88–1.56)

0.269

Hypertension

1.76 (1.40–2.20)

 < 0.001

1.37 (1.08–1.73)

0.009

Diabetes

1.34 (1.03–1.75)

0.030

1.11 (0.84–1.45)

0.462

Dyslipidemia

0.90 (0.71–1.15)

0.400

0.93 (0.73–1.19)

0.560

SPI

 0

Reference

 

Reference

 

 1

1.69 (1.11–2.57)

0.014

1.20 (0.78–1.83)

0.408

 2

1.95 (1.54–2.47)

 < 0.001

1.35 (1.05–1.73)

0.019

  1. SPI stenosis proximal involvement, HR hazard ratios, CI confidence intervals, MACE major adverse cardiovascular events.